Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALGeneric

E.E.S. 400

ERYTHROMYCIN ETHYLSUCCINATE

Standard Dose
EQ 400MG BASE/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary

Approval overview E.E.S. 400 is listed in Drugs@FDA under application 061639 (ANDA).

Review priority: STANDARD Marketing status: Discontinued Active ingredient ERYTHROMYCIN ETHYLSUCCINATE Form and strength SUSPENSION;ORAL - EQ 400MG BASE/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** Sponsor ARBOR PHARMS LLC Submission history Latest submission status date: 2015-09-01 00:00:00.

Structured Monograph

Clinical summary

Approval overview E.E.S. 400 is listed in Drugs@FDA under application 061639 (ANDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient ERYTHROMYCIN ETHYLSUCCINATE Form and strength SUSPENSION;ORAL - EQ 400MG BASE/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** Sponsor ARBOR PHARMS LLC Submission history Latest submission status date: 2015-09-01 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Discontinued
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.